CVR number 55154015
Industry 32.5000 Manufacture of medical and dental instruments and supplies

ORTOPÆDI-SKOMAGERI KAJ LARSEN & SØN A/S

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
Bankruptcy risk for industry  2.2% 2.2% 2.2% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 0.0% 5.4% 12.4%  
Credit score (0-100)  0 0 0 44 21  
Credit rating  N/A N/A N/A BBB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 0.0 759 474  
EBITDA  0.0 0.0 0.0 -97.8 -450  
EBIT  0.0 0.0 0.0 -145 -450  
Pre-tax profit (PTP)  0.0 0.0 0.0 -165.9 -468.3  
Net earnings  0.0 0.0 0.0 -166.1 -466.0  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 -166 -468  
 
See the entire income statement

Balance sheet (kDKK) 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
Tangible assets total  0.0 0.0 0.0 141 0.0  
Shareholders equity total  0.0 0.0 0.0 410 0.0  
Interest-bearing liabilities  0.0 0.0 0.0 329 228  
Balance sheet total (assets)  0.0 0.0 0.0 1,016 574  
Net Debt  0.0 0.0 0.0 256 -157  
 
See the entire balance sheet

Volume 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 0.0 759 474  
Gross profit growth  0.0% 0.0% 0.0% 0.0% -37.6%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 0 1,016 574  
Balance sheet change%  0.0% 0.0% 0.0% 0.0% -43.5%  
Added value  0.0 0.0 0.0 -144.9 -450.1  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 94 -141  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 0.0 -1.0 -2.0  

Profitability 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 0.0% -19.1% -95.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 0.0% -14.0% -56.4%  
ROI %  0.0% 0.0% 0.0% -19.2% -92.8%  
ROE %  0.0% 0.0% 0.0% -40.5% -94.7%  

Solidity 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
Equity ratio %  0.0% 0.0% 0.0% 40.4% 0.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% -261.7% 34.8%  
Gearing %  0.0% 0.0% 0.0% 80.1% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 14.6% 7.1%  

Liquidity 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
Quick Ratio  0.0 0.0 0.0 0.7 1.7  
Current Ratio  0.0 0.0 0.0 3.0 1.7  
Cash and cash equivalent  0.0 0.0 0.0 72.6 384.7  

Capital use efficiency 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 0.0 568.2 228.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0